335
Views
2
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Association of Metabolically Healthy Obesity and Risk of Cardiovascular Disease Among Adults in China: A Retrospective Cohort Study

, , , & ORCID Icon
Pages 151-159 | Received 17 Nov 2022, Accepted 10 Jan 2023, Published online: 19 Jan 2023

References

  • Roth GA, Forouzanfar MH, Moran AE, et al. Demographic and epidemiologic drivers of global cardiovascular mortality. N Engl J Med. 2015;372(14):1333–1341. doi:10.1056/NEJMoa1406656
  • Zhao L, Li D, Zheng H, et al. Acupuncture as adjunctive therapy for chronic stable angina: a randomized clinical trial. JAMA Intern Med. 2019;179(10):1388–1397. doi:10.1001/jamainternmed.2019.2407
  • Gao M, Lv J, Yu C, et al. Metabolically healthy obesity, transition to unhealthy metabolic status, and vascular disease in Chinese adults: a cohort study. PLoS Med. 2020;17(10):e1003351. doi:10.1371/journal.pmed.1003351
  • Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American heart association/national heart, lung, and blood institute scientific statement. Circulation. 2005;112(17):2735–2752. doi:10.1161/CIRCULATIONAHA.105.169404
  • Jaiswal S, Natarajan P, Silver AJ, et al. Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease. N Engl J Med. 2017;377(2):111–121. doi:10.1056/NEJMoa1701719
  • Ning F, Ren J, Song X, et al. Famine exposure in early life and risk of metabolic syndrome in adulthood: comparisons of different metabolic syndrome definitions. J Diabetes Res. 2019;2019:7954856. doi:10.1155/2019/7954856
  • Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640–1645. doi:10.1161/CIRCULATIONAHA.109.192644
  • Stefan N, Häring H-U, Schulze MB. Metabolically healthy obesity: the low-hanging fruit in obesity treatment? Lancet Diabetes Endocrinol. 2018;6(3):249–258. doi:10.1016/s2213-8587(17)30292-9
  • Zheng R, Yang M, Bao Y, et al. Prevalence and determinants of metabolic health in subjects with obesity in Chinese population. Int J Environ Res Public Health. 2015;12(11):13662–13677. doi:10.3390/ijerph121113662
  • Aung K, Lorenzo C, Hinojosa MA, Haffner SM. Risk of developing diabetes and cardiovascular disease in metabolically unhealthy normal-weight and metabolically healthy obese individuals. J Clin Endocrinol Metab. 2014;99(2):462–468. doi:10.1210/jc.2013-2832
  • Schulze MB. Metabolic health in normal-weight and obese individuals. Diabetologia. 2019;62(4):558–566. doi:10.1007/s00125-018-4787-8
  • Stefan N, Schick F, Haring HU. Causes, characteristics, and consequences of metabolically unhealthy normal weight in humans. Cell Metab. 2017;26(2):292–300. doi:10.1016/j.cmet.2017.07.008
  • Consultation WE. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363(9403):157–163. doi:10.1016/s0140-6736(03)15268-3
  • Guo J, Wu Y, Zhu Z, et al. Global genetic differentiation of complex traits shaped by natural selection in humans. Nat Commun. 2018;9(1):1865. doi:10.1038/s41467-018-04191-y
  • He W, Li Q, Yang M, et al. Lower BMI cutoffs to define overweight and obesity in China. Obesity. 2015;23(3):684–691. doi:10.1002/oby.20995
  • Choi S, Kim K, Kim SM, et al. Association of obesity or weight change with coronary heart disease among young adults in South Korea. JAMA Intern Med. 2018;178(8):1060–1068. doi:10.1001/jamainternmed.2018.2310
  • He K, Zhang W, Hu X, et al. Relationship between multimorbidity, disease cluster and all-cause mortality among older adults: a retrospective cohort analysis. BMC Public Health. 2021;21(1):1080. doi:10.1186/s12889-021-11108-w
  • Zhou BF. Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults--study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Biomed Environ Sci. 2002;15(1):83–96.
  • Eckel N, Meidtner K, Kalle-Uhlmann T, Stefan N, Schulze MB. Metabolically healthy obesity and cardiovascular events: a systematic review and meta-analysis. Eur J Prev Cardiol. 2016;23(9):956–966. doi:10.1177/2047487315623884
  • Huang MY, Wang MY, Lin YS, et al. The association between metabolically healthy obesity, cardiovascular disease, and all-cause mortality risk in Asia: a systematic review and meta-analysis. Int J Environ Res Public Health. 2020;17(4). doi:10.3390/ijerph17041320
  • Cordola Hsu AR, Ames SL, Xie B, et al. Incidence of diabetes according to metabolically healthy or unhealthy normal weight or overweight/obesity in postmenopausal women: the women’s health initiative. Menopause. 2020;27(6):640–647. doi:10.1097/GME.0000000000001512
  • Hsueh YW, Yeh TL, Lin CY, et al. Association of metabolically healthy obesity and elevated risk of coronary artery calcification: a systematic review and meta-analysis. PeerJ. 2020;8:e8815. doi:10.7717/peerj.8815
  • Lin L, Zhang J, Jiang L, et al. Transition of metabolic phenotypes and risk of subclinical atherosclerosis according to BMI: a prospective study. Diabetologia. 2020;63(7):1312–1323. doi:10.1007/s00125-020-05116-5
  • Zhou Z, Macpherson J, Gray SR, et al. Are people with metabolically healthy obesity really healthy? A prospective cohort study of 381,363 UK biobank participants. Diabetologia. 2021;64(9):1963–1972. doi:10.1007/s00125-021-05484-6
  • Itoh H, Kaneko H, Kiriyama H, et al. Metabolically healthy obesity and the risk of cardiovascular disease in the general population- analysis of a nationwide epidemiological database. Circ J. 2021;85(6):914–920. doi:10.1253/circj.CJ-20-1040
  • Lee J, Kwak SY, Park D, Kim GE, Park CY, Shin MJ. Prolonged or transition to metabolically unhealthy status, regardless of obesity status, is associated with higher risk of cardiovascular disease incidence and mortality in Koreans. Nutrients. 2022;14(8). doi:10.3390/nu14081644
  • Wang W, He J, Hu Y, et al. Comparison of the incidence of cardiovascular diseases in weight groups with healthy and unhealthy metabolism. Diabetes Metab Syndr Obes. 2021;14:4155–4163. doi:10.2147/DMSO.S330212
  • Zheng Q, Lin W, Liu C, et al. Prevalence and epidemiological determinants of metabolically obese but normal-weight in Chinese population. BMC Public Health. 2020;20(1):487. doi:10.1186/s12889-020-08630-8
  • Ding C, Chan Z, Magkos F. Lean, but not healthy: the ‘metabolically obese, normal-weight’ phenotype. Curr Opin Clin Nutr Metab Care. 2016;19(6):408–417. doi:10.1097/MCO.0000000000000317
  • Mongraw-Chaffin M, Foster MC, Anderson CAM, et al. Metabolically healthy obesity, transition to metabolic syndrome, and cardiovascular risk. J Am Coll Cardiol. 2018;71(17):1857–1865. doi:10.1016/j.jacc.2018.02.055
  • Kouvari M, Panagiotakos DB, Yannakoulia M, et al. Transition from metabolically benign to metabolically unhealthy obesity and 10-year cardiovascular disease incidence: the ATTICA cohort study. Metabolism. 2019;93:18–24. doi:10.1016/j.metabol.2019.01.003
  • Lee SH, Yang HK, Ha HS, et al. Changes in metabolic health status over time and risk of developing type 2 diabetes: a prospective cohort study. Medicine. 2015;94(40):e1705. doi:10.1097/MD.0000000000001705
  • Mohan V, Unnikrishnan R, Shobana S, Malavika M, Anjana RM, Sudha V. Are excess carbohydrates the main link to diabetes & its complications in Asians? Indian J Med Res. 2018;148(5):531–538. doi:10.4103/ijmr.IJMR_1698_18
  • Kelley DE, Thaete FL, Troost F, Huwe T, Goodpaster BH. Subdivisions of subcutaneous abdominal adipose tissue and insulin resistance. Am J Physiol Endocrinol Metab. 2000;278(5):E941–E948. doi:10.1152/ajpendo.2000.278.5.E941
  • Haldar S, Chia SC, Henry CJ. Body composition in Asians and caucasians: comparative analyses and influences on cardiometabolic outcomes. Adv Food Nutr Res. 2015;75:97–154. doi:10.1016/bs.afnr.2015.07.001
  • Stefan N. Identification and characterization of metabolically benign obesity in humans. Arch Intern Med. 2008;168(15):1609. doi:10.1001/archinte.168.15.1609
  • Tran TT, Yamamoto Y, Gesta S, Kahn CR. Beneficial effects of subcutaneous fat transplantation on metabolism. Cell Metab. 2008;7(5):410–420. doi:10.1016/j.cmet.2008.04.004
  • Gray SL, Vidal-Puig AJ. Adipose tissue expandability in the maintenance of metabolic homeostasis. Nutr Rev. 2007;65(6):7–12. doi:10.1301/nr.2007.jun.S7-S12
  • Laclaustra M, Corella D, Ordovas JM. Metabolic syndrome pathophysiology: the role of adipose tissue. Nutr Metab Cardiovasc Dis. 2007;17(2):125–139. doi:10.1016/j.numecd.2006.10.005
  • Liu J, Musani SK, Bidulescu A, et al. Fatty liver, abdominal adipose tissue and atherosclerotic calcification in African Americans: the Jackson Heart Study. Atherosclerosis. 2012;224(2):521–525. doi:10.1016/j.atherosclerosis.2012.07.042
  • Neeland IJ, Ayers CR, Rohatgi AK, et al. Associations of visceral and abdominal subcutaneous adipose tissue with markers of cardiac and metabolic risk in obese adults. Obesity. 2013;21(9):E439–E447. doi:10.1002/oby.20135
  • Neeland IJ, Poirier P, Despres JP. Cardiovascular and metabolic heterogeneity of obesity: clinical challenges and implications for management. Circulation. 2018;137(13):1391–1406. doi:10.1161/CIRCULATIONAHA.117.029617
  • Achilike I, Hazuda HP, Fowler SP, Aung K, Lorenzo C. Predicting the development of the metabolically healthy obese phenotype. Int J Obes. 2015;39(2):228–234. doi:10.1038/ijo.2014.113
  • Appleton SL, Seaborn CJ, Visvanathan R, et al. Diabetes and cardiovascular disease outcomes in the metabolically healthy obese phenotype: a cohort study. Diabetes Care. 2013;36(8):2388–2394. doi:10.2337/dc12-1971
  • Moussa O, Arhi C, Ziprin P, Darzi A, Khan O, Purkayastha S. Fate of the metabolically healthy obese-is this term a misnomer? A study from the clinical practice research Datalink. Int J Obes. 2019;43(5):1093–1101. doi:10.1038/s41366-018-0096-z